Roman Kniazev, CEO of Nuravax, has emerged as one of biotech's most effective fundraisers, securing a mix of competitive grants and private investments to advance innovative drug programs. Kniazev shared some practical insights on navigating biotech's complex fundraising and clinical development landscape.
Archives
Trump Reshapes Nuclear Oversight with Orders to Speed Project Approvals
Trump signs orders to fast-track US nuclear power projects and boost production amid rising energy demands.
McDonald's to Close All CosMc's Locations Starting in June
McDonald's will close all CosMc's locations in June, ending its beverage-focused chain just two years after launch.
Trump Says That He Expects 'iPhones That Will be Sold in the United States to be Made Here'
Trump warns Apple of a 25% tariff if it doesn't move iPhone production to the US.
Boeing Settles with DOJ for $1.1 Billion Over 737 Max Crashes
Boeing settles with DOJ for $1.1 billion to avoid prosecution over 737 Max crashes that killed 346 people.
Latest News
23andMe's sale to Regeneron transfers genetic data for drug development, raising privacy issues and concerns over consumer control and benefits.
Levi's sells Dockers to Authentic Brands for $311 million to focus on denim, global growth, and core brand strategy.
Japan's agriculture minister resigns after controversial rice comment amid rising food prices and public backlash.
Home Depot commits to keeping prices steady despite tariffs, setting itself apart from Walmart's planned price hikes.
Cucumbers recalled in 15 states after a Salmonella outbreak sickens 26 people and hospitalizes 9.
Elon Musk says he's cutting back on political donations after backing Trump with over $250 million in 2024.
Walmart CFO warns shoppers may see higher prices by late May due to rising import tariffs.
A judge tosses Vanguard's $40M investor settlement, citing overlap with an earlier SEC payout.
CBS News CEO Wendy McMahon resigns amid legal battles and settlement talks with Donald Trump.
